← Eichor
Study identifier: NCT04393389 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Acotec DCB Post Market Clinical Follow-up

Condition: Peripheral Artery Disease  ·  Sponsor: Acotec Scientific Co., Ltd

PhaseN/A
Planned participants3000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

All-comers, prospective, multi-center, single-arm, non-interventional post market clinical follow-up (PMCF) Cohort 1 - Claudicants: Rutherford Clinical Category (RCC) 2-3 Cohort 2 - Critical Limb Ischemia: Rutherford Clinical Category (RCC) 4-6

This description comes directly from the study's public registry record.

Talk to the study team

Schmidt Andrej  ·  +49-341-97  ·  Andrej.Schmidt@medizin.uni-leipzig.de

Always discuss trial participation with your own doctor first.

Locations (7)

HalleHalle, Saxony-Anhalt, GermanyRecruiting
EilenburgEilenburg, GermanyRecruiting
Department of Angiology, University Hospital Leipzig,Leipzig, GermanyRecruiting
Elblandklinikum RadebeulRadebeul, GermanyRecruiting
Elblandklinikum RadebeulRiesa, GermanyRecruiting
REGIOMED Klinikum SonnebergSonneberg, GermanyRecruiting
KKH TorgauTorgau, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04393389